J. Hulthe

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

Lars Lind, Lars Wallentin, Tibor Kempf et al. · European Heart Journal · 2009 · 235 citations

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Lars Gullestad, Thor Ueland, John Kjekshus et al. · European Heart Journal · 2012 · 152 citations · Full text

Circulating oxidized low‐density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58‐year‐old men (AIR study)

V. Sigurdardottir, Björn Fagerberg, J. Hulthe · Journal of Internal Medicine · 2002 · 145 citations · Full text

Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction

Ann Samnegård, Angela Silveira, Pia Lundman et al. · Journal of Internal Medicine · 2005 · 126 citations · Full text

Oxidized low‐density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men

K. Wallenfeldt, Björn Fagerberg, John Wikstrand et al. · Journal of Internal Medicine · 2004 · 117 citations

Vascular Disease, Low‐density Lipoprotein, Hyperlipidemia +21